Osiris Therapeutics Announces First Quarter 2014 Financial Results Conference Call

Lode Debrabandere, Ph.D., President and Chief Executive Officer, and Philip R. Jacoby, Jr., Chief Financial Officer, will provide a company update and discuss results via a webcast and conference call on Tuesday, May 13, 2014, at 9:00 a.m. ET.

http://ift.tt/1ivILkD